AKT1 and Epstein-Barr virus infection: To our knowledge, EBER-mediated activation of AKT has not been documented previously even though the PI3K-AKT signaling cascade is a known target of the EBV oncoprotein LMP1 [18, 35] and a recent bioinformatics study showed that EBV infection affects alternative splicing [53].